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TITLE: MITOMYCIN C AND 5-FLUOROURACYLTOXICITY IN 
HUMAN RPE CELLS CULTURE. 
AUTHORS: Cam-Parra J', Navea A2, Ruiz-Lapuente 
C', Martinez-Palmer A', Castilla M', GBmez-Lechbn 
MJ*, Diaz M2. 
l.- IMIM, Barcelona. 
2.- La Fe Hospital, ValenCia. 
PURPOSE: We studied the effects of exposure to 
mitomycin C and 5-Fluorcuracil to human RPE 
cultures, in growth inhibition and citoxicity. 
METHODS: 1) Growth inhibition: RPE cultures 
(3.000 cells/well) were exposed to different 
concentrations of mitomycin C and 5-Fluorouracil, 
and cell viability (MTT test) was evaluated 48h, 
72h and 96h after. 2) Citotoxicity: RPE cultures 
(10.000 cells/well) were exposed to different 
concentrations of mitomVcin C and 5-Fluorouracil, 
and cell viability (MT? test) was evaluated 96h 
after. 
RESULTS: 1) Growth inhibition: IC,o (!Jcl/ml) o= 
dose that produced 50% RPE growth inhibition was 
at 48 h 0.86; and at 96 h 0.43 for the mitomycin, 
whereas it ias at 48 h 6.311; and at 96h 1.36 for 
5-fluorouracil. 2) Citotoxicity: IC,, (pg/ml) or 
dose that produced 50% RPE zitotoxicity was at 96 
h 0.09 for the mitomvcin. whereas it was at 96h 
0.55 for 5-fluorouracil. 
CONCLUSIONS: Mitomycin C at lower doses has a 
higher effect on RPE growth inhibition and 
citotoxicity than 5-fluorouracil. 
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NEW ADVANCE IN THE TREATMENT OF THE RETINOPATHY OF 
PREMATURITY: LASER DIODE PtiOTOCOAGLkATION. 
GONZALEZ I. FERRER C. PUEYO M. VldENTE E. BUENO J 
HONRUBIA FM. 
Service of Ophthalmology. Hospital Miguel Seivet. Zaragoza. (SPAIN) 
Puroose: We have used the diode laser photocoagulation in the 
treatment of the retinopathy of prematurity (ROP). 
Methods: We have treated 22 eyes of 12 patients with ROP.3 Infants 
have been followad up for at least :3 months and 9 infants have been 
followed up for at least one year. The indication of treatment has been: 
zone I with “plus” disease, any stage; zone II with “$I&’ disease, stage 
2 or zone II stage 3. Treatment was administered within 72 hours after 
the diagnosis and topical anesthesia and sedation was used In all 
cases 
m: We have treated 14 eyes with threshold disease and 8 eyes 
with prethreshold disease. No evidence of lesions of the anterior 
segment or vitreous hemorrhage were found after the treatment. 
External inflammatory sings wera almost nonexistent. Systemic 
complications occurred only in 3 sessions of treatment. 8114 eyes 
(57%) with threshold disease and 818 eyes (100%) with prethreshold 
disease have a favorable outcome. In total, 16122 eyes (73%) with 
ROP have favorable outcome. 
Conclusion: Treatment with diode laser is easily performed, effecl~ve. 
essentially in oases of prethreshold disease but too in cases of 
threshold disease, and with slight ocular or systemic complications 
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Put-Dose: Diode trans-scleral photocoagulation may 
be an alternative to cryotherapy for the treatment 
of proliferative diabetic retinopathy in cases of 
opacity of media. In this paper we try compare the 
wound caused by the diode laser applied via trans- 
scleral vs transpupillary. 
Method&: We have studied 10 eyes of 10 pigmented 
rabbits weighted 3 Kg. Under general anesthesia, in 
5 rabbits we performed a trans-scleral photocoagu- 
lation (5 impacts, 500 miliwatts, l-Z-5 ssc dura- 
tion). In 4 rabbits we performed transpupillary 
photocoagulation (15 impacts, 150 miliwatts, 0.1- 
0.2 sec.).We evaluated the histopathologic effects, 
surgical complications and ophthalmoscopic results. 
Results: The trans-scleral photocoagulation techni- 
que is similar to that used in crvotsrapy. The 
ophthalmoscopic image depends of the time ii expo- 
sure, to longer duration more whitenning of the re- 
tina. We didn’t observe hemorrhages nor another 
side-effects caused by the technique. The histopa- 
thologic study showed that wounds in both groups 
wars similar (alterations in photo-receptors-layer 
and pigment spithelium, outer plexiform and gan- 
glion cells). 
Conclusions: Trans-scleral photocoagulation is a 
simple technique to us8 and do not present compli- 
cations or side effects. The histopathologic wound 
is similar to that obtained with transpupillary 
photocoagulation. The technique is safe and coulb 
be applied in cases of opaqus media in prolifera- 
tive retinopathy. More experiencies ars needed. 
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